facebook twitter linkedin

This material was prepared by a third party towards Selvita S.A. with its registered office in Kraków (hereunder: “Selvita”). Within the scope which was not authorized by Selvita’s management board, the description of factual circumstances regarding the activities of Selvita, embodied in this material presents merely opinion of the third party, in particular with respect to presented opinions, predictions, appraisals and forecasts of the financial data and future activity of Selvita and its results.

Therefore, Selvita does not warrant consistency of this material with the actual and legal situation. Neither Selvita, members of its corporate bodies, employees nor its consultants shall bear any liability for validity of opinions, predictions, appraisals, forecasts and any other date embodied in this material as well as for consequences of actions of any reader made on a basis of this material, in particular for the investment decisions or any losses resulting from use of this material.

Readers of this material shall make its own assessment, whether opinions or forecasts embodied therein are credible and adequate, in particular taking into account their investment strategy and actual and legal situation. In particular they should consult it with their independent financial and investment advisors. None of the information presented in this material shall constitute investment, legal, accounting or tax advice or a statement that any investment strategy is accurate or adequate, considering the circumstances of the reader.

Furthermore date presented in this material shall not constitute an offer to sell or purchase any financial instruments nor an invite the make such offer. It shall not be also not deemed as a recommendation for investment in any financial instrument nor an advertisement of such instruments.

Place: Zurich, January 25th-26th, 2011, Radisson Blu Hotel (Zurich Airport)
Building on the success of the 2010 event, the 4th Annual European Life Science CEO Forum for Partnering and Investing is an exclusive and highly transactional forum for investing and partnering in the Biotech and Pharma industry. Attended by 300 delegates over a two-day program, the forum will provide you with truly excellent networking opportunities with 500 meeting slots available, allowing access to some of the brightest players in the industry. This event is a must for companies wishing to meet with their peers, engage with leading investors and forge new 
Selvita will also hold a presentation during this event, details of which will be announced soon.
To contact Selvita's delegate at this conference please email at: selvita@selvita.com
More information about the conference